Research Models & Releases·arXiv cs.LG·May 11

Predictive Radiomics for Evaluation of Cancer Immune SignaturE in Glioblastoma: the PRECISE-GBM study

Researchers developed machine learning models to extract immune-signature biomarkers from MRI scans of glioblastoma tumors, using radiomics and deep learning segmentation across five major cancer datasets. The work demonstrates how multimodal AI can bridge imaging and genomics to improve patient stratification without additional sequencing, potentially accelerating clinical adoption of precision oncology workflows where computational feature extraction replaces costly molecular profiling.

Modelwire context

Explainer

The study doesn't just apply radiomics to glioblastoma; it demonstrates that MRI-derived features can proxy for immune genomic signatures well enough to stratify patients without molecular profiling. That substitution is the actual claim, and it hinges on whether the learned features generalize across five independent datasets (TCGA-GBM, CPTAC, IvyGAP, REMBRANDT, CGGA).

This work sits in the same methodological family as the Gaussian process paper from today (arXiv cs.LG, 2026-05-11), which also bridges classical probabilistic inference with learned representations to maintain interpretability while scaling computation. Both papers solve a production friction point: practitioners need uncertainty quantification and feature transparency, not just point predictions. The radiomics study adds a clinical angle by showing that learned image features can replace expensive molecular assays, whereas the GP paper addresses the broader computational tradeoff between expressiveness and tractability across diverse data types.

If PRECISE-GBM's immune-signature predictions correlate with immunotherapy response rates in a prospective glioblastoma cohort within 18 months, the substitution claim holds and adoption barriers drop significantly. If the correlation breaks down or requires per-institution recalibration, the generalization across datasets was statistical artifact rather than biological signal.

Coverage we drew on

Scalable Gaussian process inference via neural feature maps · arXiv cs.LG

This analysis is generated by Modelwire’s editorial layer from our archive and the summary above. It is not a substitute for the original reporting. How we write it.

MentionsTCGA-GBM · CPTAC · IvyGAP · REMBRANDT · CGGA · PRECISE-GBM

Read full story at arXiv cs.LG →(arxiv.org)

Modelwire Editorial

This synthesis and analysis was prepared by the Modelwire editorial team. We use advanced language models to read, ground, and connect the day’s most significant AI developments, providing original strategic context that helps practitioners and leaders stay ahead of the frontier.

Our mission How we write

Modelwire summarizes, we don’t republish. The full content lives on arxiv.org. If you’re a publisher and want a different summarization policy for your work, see our takedown page.